Takeda completes ARIAD buy by Selina McKee | Feb 17, 2017 | News | 0 Takeda has now completion of its $5.2 billion acquisition of ARIAD Pharmaceuticals, in a deal that significantly boosts the Japanese drugmaer’s global cancer portfolio. Read More
Takeda shells out $5.2bn on Ariad by Selina McKee | Jan 10, 2017 | News | 0 Takeda has announced its intention to buy US drugmaker Ariad for around $5.2 billion, in a move designed to boost its oncology offering. Read More